SE509715C2 - Injicerbar lösning och förfarande för framställning av densamma - Google Patents

Injicerbar lösning och förfarande för framställning av densamma

Info

Publication number
SE509715C2
SE509715C2 SE9003523A SE9003523A SE509715C2 SE 509715 C2 SE509715 C2 SE 509715C2 SE 9003523 A SE9003523 A SE 9003523A SE 9003523 A SE9003523 A SE 9003523A SE 509715 C2 SE509715 C2 SE 509715C2
Authority
SE
Sweden
Prior art keywords
bis
gluconate
zinc
indole alkaloid
hydroxybenzoate
Prior art date
Application number
SE9003523A
Other languages
English (en)
Swedish (sv)
Other versions
SE9003523D0 (sv
SE9003523L (sv
Inventor
Maria Gazdag
Gabor Zsepesi
Nagy Geza Takacsi
Zsofia Papp
Laszlo Nagy
Monika Zsoldos
Eva Eszter Kiss
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE9003523D0 publication Critical patent/SE9003523D0/xx
Publication of SE9003523L publication Critical patent/SE9003523L/
Publication of SE509715C2 publication Critical patent/SE509715C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Press Drives And Press Lines (AREA)
  • Press-Shaping Or Shaping Using Conveyers (AREA)
  • Powder Metallurgy (AREA)
SE9003523A 1989-11-07 1990-11-06 Injicerbar lösning och förfarande för framställning av densamma SE509715C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (3)

Publication Number Publication Date
SE9003523D0 SE9003523D0 (sv) 1990-11-06
SE9003523L SE9003523L (sv) 1991-05-08
SE509715C2 true SE509715C2 (sv) 1999-03-01

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003523A SE509715C2 (sv) 1989-11-07 1990-11-06 Injicerbar lösning och förfarande för framställning av densamma

Country Status (37)

Country Link
US (1) US5397784A (xx)
JP (1) JP3042702B2 (xx)
KR (1) KR0164601B1 (xx)
CN (1) CN1053569C (xx)
AR (1) AR245592A1 (xx)
AT (1) AT401469B (xx)
AU (1) AU638504B2 (xx)
BE (1) BE1004051A4 (xx)
BG (1) BG60609B1 (xx)
CA (1) CA2029368C (xx)
CH (1) CH682130A5 (xx)
CZ (1) CZ279433B6 (xx)
DE (1) DE4035253B4 (xx)
DK (1) DK266390A (xx)
ES (1) ES2026062A6 (xx)
FI (1) FI100455B (xx)
FR (1) FR2653998B1 (xx)
GB (1) GB2238241B (xx)
GR (1) GR1001041B (xx)
HU (1) HU204995B (xx)
IE (1) IE62387B1 (xx)
IL (1) IL96249A (xx)
IT (1) IT1242724B (xx)
LT (1) LT3334B (xx)
LV (1) LV10687B (xx)
MY (1) MY104595A (xx)
NL (1) NL9002412A (xx)
NO (1) NO175565C (xx)
NZ (1) NZ236005A (xx)
PL (1) PL164881B1 (xx)
PT (1) PT95810B (xx)
RU (1) RU1828401C (xx)
SE (1) SE509715C2 (xx)
SK (1) SK278421B6 (xx)
UA (1) UA13162A (xx)
YU (1) YU48373B (xx)
ZA (1) ZA908855B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
IT1170152B (it) 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
NL9002412A (nl) 1991-06-03
BE1004051A4 (fr) 1992-09-15
PL164881B1 (en) 1994-10-31
DK266390A (da) 1991-05-08
GB2238241A (en) 1991-05-29
SE9003523D0 (sv) 1990-11-06
JP3042702B2 (ja) 2000-05-22
CH682130A5 (xx) 1993-07-30
FI100455B (fi) 1997-12-15
RU1828401C (ru) 1993-07-15
ATA223090A (de) 1996-02-15
FR2653998A1 (fr) 1991-05-10
IT1242724B (it) 1994-05-17
DK266390D0 (da) 1990-11-06
IL96249A0 (en) 1991-08-16
SK540290A3 (en) 1997-05-07
GB9024222D0 (en) 1990-12-19
UA13162A (uk) 1997-02-28
LV10687A (lv) 1995-06-20
CZ279433B6 (cs) 1995-04-12
SK278421B6 (en) 1997-05-07
YU209590A (sh) 1993-05-28
CA2029368A1 (en) 1991-05-08
ES2026062A6 (es) 1992-04-01
MY104595A (en) 1994-04-30
DE4035253A1 (de) 1991-05-08
HU204995B (en) 1992-03-30
NO904821D0 (no) 1990-11-06
US5397784A (en) 1995-03-14
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
CZ540290A3 (en) 1994-11-16
IE62387B1 (en) 1995-01-25
ZA908855B (en) 1991-08-28
HU895804D0 (en) 1990-01-28
IT9067868A1 (it) 1992-05-06
NO175565B (no) 1994-07-25
HUT55225A (en) 1991-05-28
PT95810A (pt) 1991-09-13
LTIP512A (en) 1994-11-25
KR0164601B1 (ko) 1999-01-15
GB2238241B (en) 1993-10-06
KR910009245A (ko) 1991-06-28
AR245592A1 (es) 1994-02-28
FR2653998B1 (fr) 1995-02-17
IT9067868A0 (it) 1990-11-06
IE903993A1 (en) 1991-05-08
CA2029368C (en) 2000-01-04
GR900100795A (en) 1992-04-17
BG60609B1 (bg) 1995-10-31
FI905508A0 (fi) 1990-11-07
NO175565C (no) 1994-11-02
SE9003523L (sv) 1991-05-08
GR1001041B (el) 1993-03-31
LT3334B (en) 1995-07-25
DE4035253B4 (de) 2004-10-07
LV10687B (en) 1995-12-20
CN1053185A (zh) 1991-07-24
AT401469B (de) 1996-09-25
IL96249A (en) 1995-07-31
CN1053569C (zh) 2000-06-21
YU48373B (sh) 1998-07-10
NO904821L (no) 1991-05-08
AU6584590A (en) 1991-05-16
AU638504B2 (en) 1993-07-01
JPH03206040A (ja) 1991-09-09

Similar Documents

Publication Publication Date Title
US4409233A (en) Highly concentrated preparations of dopa compounds
FI78837B (fi) Foerfarande foer framstaellning av en foer injektionsadministration laemplig, stabil och saltsyrahaltig vattenloesning av cis-platina.
SE509715C2 (sv) Injicerbar lösning och förfarande för framställning av densamma
US4780465A (en) Aqueous solution containing a quinolone carboxylic acid
EP0397147B1 (en) Stable solutions of rebeccamycin analog and preparation thereof
JPH0674212B2 (ja) 塩化ベンザルコニウム含有水性製剤の配合禁忌防止方法
HU195513B (en) Process for producing stable solutions of alkaloides with bis-indole skeleton
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
AU613810B2 (en) Cisplatin hypertonic solution
HU181940B (en) Process for producing solutions of vincane derivatives for parentheral application
HU211477A9 (hu) Bisz-indol-alkaloid-sót tartalmazó injekciós oldat
KR20210101193A (ko) 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제
JPH06700B2 (ja) 安定な水性液剤
SI9012095A (sl) Injekcijska raztopina in postopek za njeno pridobivanje
EP1013277A1 (en) Freeze-dried preparations and process for producing the same

Legal Events

Date Code Title Description
NUG Patent has lapsed